http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA02001238-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2002-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91212d7cee1c43a4110641fdc58e155c |
| publicationDate | 2003-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA02001238-A |
| titleOfInvention | USE OF HYDRALAZINE AND PROCANAIMIDE IN THE TREATMENT OF CANCER AS REAGENTS OF EXPRESSION OF TUMOR SUPPRESSING GENES. |
| priorityDate | 2002-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3637 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492078 |
Total number of triples: 12.